Pharmascience Inc. contributes to the Montreal Heart Institute's COLchicine Cardiovascular Outcome T


MONTREAL, Nov. 16, 2019 /CNW/ - The Montreal Heart Institute (MHI) announced earlier today the results of its COLchicine Cardiovascular Outcomes Trial (COLCOT). ... Lees verder

Bron: ANP Pers support
Tags:
Geplaatst: 16 nov 2019 - 18:01